DF6215

· Dragonfly Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DF6215, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of DF6215 in Patients With Advanced Solid Tumors [Phase 1]